OPTICYTE
LIVE

Serial Number

90025742

Owner

MERAKRIS THERAPEUTICS, INC.

Attorney

Karen Hahn

First Use Date

Aug 18, 2017

Filing Date

Jun 29, 2020

Add to watchlist:

No watchlists yet
View on USPTO

OPTICYTE Trademark

Serial Number: 90025742 • Registration: 6256450

OPTICYTE is a trademark filed by MERAKRIS THERAPEUTICS, INC. on June 29, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

MERAKRIS THERAPEUTICS, INC. (3 trademarks)

800 PARK OFFICES DRIVE; SUITE 403
RESEARCH TRIANGLE PARK, NC 27709

Entity Type: 03

Merakris Therapeutics, LLC (2 trademarks)

800 Park Offices Drive; Suite 3305
Research Triangle Park, NC 27709

Entity Type: 16

Trademark Details

Filing Date

June 29, 2020

Registration Date

January 26, 2021

First Use Anywhere

August 18, 2017

First Use in Commerce

May 5, 2020

Published for Opposition

November 10, 2020

Goods & Services

Human biological amniotic membrane or other postpartum tissues intended for subsequent implantation; human biological amniotic tissue or other postpartum tissues that may include amniotic membrane, amniotic fluid, umbilical cord, or placenta, intended for medical use for the treatment or prevention of ophthalmic diseases, or the treatment of wounds, ulcers, burns, scars and surgical incisions involving the eye; human biological tissue, namely, placental-derived tissue for use in biological tissue grafts for use in surgery and wound repair involving the eye; topical treatment in the nature of an allograft for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions involving the eye, and the treatment or prevention of ophthalmic diseases; topical treatment made from amniotic material in the nature of a wound dressing for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions involving the eye; topical treatment made from amniotic material in the nature of an allograft for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions involving the eye; wound treatment in the nature of amniotic material prepared in sheet forms or viscous forms

Filing History

TEAS SECTION 8 & 15 RECEIVED
Apr 24, 2026 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jan 26, 2026 REM1
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jan 25, 2023 ASGN
REGISTERED-PRINCIPAL REGISTER
Jan 26, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 10, 2020 NPUB
PUBLISHED FOR OPPOSITION
Nov 10, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 21, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 30, 2020 CNSA
ASSIGNED TO EXAMINER
Sep 30, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 25, 2020 NWOS
NEW APPLICATION ENTERED
Jul 2, 2020 NWAP